Sarcopenia as a Risk Factor for Adverse Postoperative Outcomes in Inflammatory Bowel Disease (IBD)

Go Back to All Clinical Trials

Sarcopenia as a Risk Factor for Adverse Postoperative Outcomes in Inflammatory Bowel Disease (IBD)

Brief description of study

The goal of this study is to evaluate the role of sarcopenia in postoperative risk among patients with IBD, and to develop a preoperative risk stratification tool which can be used to both reduce surgical delays in low-risk patients and identify high-risk patients who may benefit from preoperative optimization (rehabilitation and nutritional support). The research will serve as foundational work to standardize measures of sarcopenia in IBD, and will serve as the basis to improve preoperative risk assessments and interventions among the IBD patient population.

Clinical Study Identifier: s22-00967

Principal Investigator: Adam Faye.

Other Investigators: Ariela Holmer, Shannon Chang, Feza Remzi, Simon J Hong, John Kirat, Jordan E Axelrad, Arman Erkan, David P Hudesman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies